Latest Bavarian Nordic News & Updates

See the latest news and media coverage for Bavarian Nordic. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Bavarian Nordic

Biopharmaceutical vaccine company

bavarian-nordic.com
Headquarters
Copenhagen, Denmark
Founded year
1994
Company type
Public company
Number of employees
1,800–5,000
Industry
Pharmaceuticals

Last updated

Latest news about Bavarian Nordic

In short: Bavarian Nordic upgraded its 2026 financial guidance, secured major vaccine contracts, and expanded its mpox vaccine use to children.

Company announcements

Bavarian Nordic

Bavarian Nordic expands mpox vaccine authorization to younger children

The European Commission authorized IMVANEX for children aged two to under twelve based on phase two trial data showing non-inferior immune responses compared to adults.

Unlock all announcements with a

Media coverage

Il Sole 24 Ore

In Copenhagen, Bavarian Nordic is trading higher, driven by the quarter, raised guidance and buy back

In the second quarter, the group's revenue increased by 23% to reach 2,034 million Danish kroner. The company will launch an additional share buyback program...

Unlock all articles with a

Never miss news about Bavarian Nordic

Track Bavarian Nordic and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Bavarian Nordic competitors & trending companies

Browse news for competitors to Bavarian Nordic and other trending companies.